Summary
Definition
History and exam
Key diagnostic factors
- unilateral weakness or paralysis in the face, arm, or leg
- sensory loss (numbness)
- dysphasia
- dysarthria
- visual disturbance
- photophobia
- headache
- ataxia
- risk factors
Other diagnostic factors
- vertigo
- nausea/vomiting
- decreased level of consciousness/coma
- confusion
- gaze paresis
Risk factors
- hypertension
- older age
- male sex
- Asian, black and/or Latino/Hispanic
- heavy alcohol use
- illicit sympathomimetic drugs
- family history of intracerebral haemorrhage
- haemophilia
- cerebral amyloid angiopathy
- sickle cell disease
- autosomal dominant mutations in the COL4A1 gene
- hereditary haemorrhagic telangiectasia
- autosomal dominant mutations in the KRIT1 gene, CCM2 gene, or PDCD10 gene
- anticoagulation
- vascular malformations
- Moyamoya disease
- pregnancy
- smoking
- non-steroidal anti-inflammatories (NSAIDs)
- obstructive sleep apnoea
- diabetes mellitus
- sympathomimetic medications
- cerebral vasculitis
- thrombocytopenia
- leukaemia
Diagnostic investigations
1st investigations to order
- non-contrast CT head
- serum glucose
- serum electrolytes
- serum urea and creatinine
- liver function tests
- FBC
- clotting screen
- ECG
Investigations to consider
- serum toxicology screen
- CT angiography (CTA) or magnetic resonance angiography (MRA) head
- CT venography or magnetic resonance venography head
- Intra-arterial cerebral angiography
Treatment algorithm
suspected intracerebral haemorrhage
confirmed intracerebral haemorrhage
Contributors
Expert advisers
Matthew Jones, MD, FRCP
Consultant Neurologist
Manchester Centre for Clinical Neurosciences
Northern Care Alliance
Honorary Senior Lecturer
University of Manchester
Manchester
UK
Disclosures
MJ is the chair of the Association of British Neurologists Education Committee (unpaid position). MJ is a faculty member of an MRCP revision course. MJ has received honoraria from Eisai for educational talks.
Acknowledgements
BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:
Fernando D. Goldenberg, MD
Clinical Associate of Neurology
Medical Director, Neuroscience ICU
Director, Neurocritical Care Education
Co-Director, Stroke Center
University of Chicago
Chicago
IL
Raisa C. Martinez, MD
Neurocritical Care Fellow
Department of Neurology
University of Chicago
Chicago
IL
Disclosures
FDG and RCM declare that they have no competing interests.
Peer reviewers
David Werring, FRCP, PhD, FESO
Professor of Clinical Neurology
Head of Research Department, Brain Repair and Rehabilitation
UCL Institute of Neurology
Honorary Consultant Neurologist
National Hospital for Neurology and Neurosurgery
University College Hospitals NHS Foundation Trust
North Thames Clinical Research Specialty Lead for Stroke
NIHR Clinical Research Network
London
UK
Disclosures
DW has received honoraria (speaking) from Bayer 2016, 2017, 2018 (talks or debates on intracerebral haemorrhage, atrial fibrillation, dementia) and honoraria (chairing) from Portola and Bayer 2019. DW has received consultancy fees from Bayer (2017; embolic stroke of undetermined source), JFB consulting (2018; PCSK9 inhibitors in stroke), Alnylam (2019; cerebral amyloid angiopathy), Portola (2019, 2020; andexanet alpha). JW was UCL Principle Investigator for NIHR clinical trials NAVIGATE-ESUS (Bayer, 2016-19), B2341002 (Pfizer 2014-2016), Action-2 (Biogen, 2016-19); Chief Investigator for OPTIMAS; steering committee and co-investigator for RESTART, TICH-2.
Editors
Helena Delgado-Cohen
Section Editor, BMJ Best Practice
Disclosures
HDC declares that she has no competing interests.
Tannaz Aliabadi-Oglesby
Lead Section Editor, BMJ Best Practice
Disclosures
TAO declares that she has no competing interests.
Julie Costello
Comorbidities Editor, BMJ Best Practice
Disclosures
JC declares that she has no competing interests.
Adam Mitchell
Drug Editor, BMJ Best Practice
Disclosures
AM declares that he has no competing interests.
Differentials
- Ischaemic stroke
- Hypertensive encephalopathy
- Hypoglycaemia
More DifferentialsGuidelines
- National clinical guideline for stroke for the United Kingdom and Ireland
- Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
More GuidelinesCalculators
NIH Stroke Score
Glasgow Coma Scale
More CalculatorsVideos
Venepuncture and phlebotomy animated demonstration
How to perform an ECG animated demonstration
More videosPatient information
Stroke: treatment
Questions to ask your doctor if you've had a stroke
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer